<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(24)</volume><submitter>Ouyang L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Pancreatic cancer (PC) can be considered a representative cancer type of the human body. As demonstrated by some studies, microRNA (miR)-499 is dysregulated in various cancer types including PC, for which chemotherapy involving 5-fluorouracil (5-FU) has long been considered the first-line therapy. However, there are complex and comprehensive mechanisms related to 5-FU, which have not been fully elucidated. This study thus aimed to examine the molecular mechanisms of 5-FU resistance through miR-499a-5p in PC.&lt;h4>Methods&lt;/h4>The expression of miR-499a-5p in PC was measured using quantitative polymerase chain reaction (PCR). MiR-499a-5p was examined &lt;i>in-vivo&lt;/i> for its effects on the malignant phenotypes of PC cells.&lt;h4>Results&lt;/h4>The results of the present study demons</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>1798</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8756217</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.</pubmed_title><pmcid>PMC8756217</pmcid><pubmed_authors>Shang QC</pubmed_authors><pubmed_authors>Lei DQ</pubmed_authors><pubmed_authors>Jin G</pubmed_authors><pubmed_authors>Zheng H</pubmed_authors><pubmed_authors>Liu RD</pubmed_authors><pubmed_authors>Ouyang L</pubmed_authors><pubmed_authors>Li HF</pubmed_authors><pubmed_authors>Hu XG</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.</name><description>&lt;h4>Background&lt;/h4>Pancreatic cancer (PC) can be considered a representative cancer type of the human body. As demonstrated by some studies, microRNA (miR)-499 is dysregulated in various cancer types including PC, for which chemotherapy involving 5-fluorouracil (5-FU) has long been considered the first-line therapy. However, there are complex and comprehensive mechanisms related to 5-FU, which have not been fully elucidated. This study thus aimed to examine the molecular mechanisms of 5-FU resistance through miR-499a-5p in PC.&lt;h4>Methods&lt;/h4>The expression of miR-499a-5p in PC was measured using quantitative polymerase chain reaction (PCR). MiR-499a-5p was examined &lt;i>in-vivo&lt;/i> for its effects on the malignant phenotypes of PC cells.&lt;h4>Results&lt;/h4>The results of the present study demons</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-20T00:39:41.666Z</modification><creation>2025-02-19T03:29:20.583Z</creation></dates><accession>S-EPMC8756217</accession><cross_references><pubmed>35071492</pubmed><doi>10.21037/atm-21-6556</doi></cross_references></HashMap>